Acompanhe os destaques das Reuniões e Conferências Anuais de 2019, com insights e discussões, tudo possibilitado pelo apoio da Boehringer Ingelheim Pharmaceuticals.
Current Perspective on Antifibrotic Therapy for Patients with IPF
2 mins • Oct 25, 2019
Charts
This show is not currently ranked in any charts.
Episódios recentes
Oct 25, 2019
Current Perspective on Antifibrotic Therapy for Patients with IPF
2 mins
Oct 25, 2019
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases (The INBUILD Trial)
2 mins
Oct 25, 2019
Goals of Care Across the Disease Continuum in IPF
3 mins
Oct 25, 2019
Emerging Diagnostic Approaches to Patients with ILD
6 mins
Oct 25, 2019
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
2 mins
Idioma
Inglês
País
Estados Unidos
Categorias
Website
Feed
Solicitar uma atualização
As atualizações podem levar alguns minutos.